• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2019.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration
    October 13, 2020
    Trax launches retail watch to help employees monitor store shelves
    October 13, 2020
    Israeli company sees promising results in blood cancer treatment trial
    October 11, 2020
    Mapi Pharma in talks to produce Covid-19 vaccine in Israel
    October 7, 2020
    Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Tr
    September 18, 2020
    Mapi Pharma Presents Glatiramer Acetate Depot (GA Depot) Results at the 8th J
    September 10, 2020
    Deloitte Digital and Trax Team Up to Revolutionize Grocery Retail in Spain
    September 9, 2020
    Trax Pioneers Artificial Intelligence-Driven Dynamic Merchandising to Help CP
    August 12, 2020
    Brick and mortar shops are here to stay, says CEO of retail analytics company
    August 11, 2020
    Amid coronavirus rally, Israeli biotech taps Wall St.
    July 22, 2020